Literature DB >> 18068497

A wake-up call for global access to salvage HIV drug regimens.

Edward J Mills1, Jean B Nachega.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 18068497     DOI： 10.1016/S0140-6736(07)61790-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011.

Authors:  M R Jordan; D E Bennett; M A Wainberg; D Havlir; S Hammer; C Yang; L Morris; M Peeters; A M Wensing; N Parkin; J B Nachega; A Phillips; A De Luca; E Geng; A Calmy; E Raizes; P Sandstrom; C P Archibald; J Perriëns; C M McClure; S Y Hong; J H McMahon; N Dedes; D Sutherland; S Bertagnolio
Journal:  Clin Infect Dis       Date:  2012-05       Impact factor: 9.079

2.  Randomized controlled trial of trained patient-nominated treatment supporters providing partial directly observed antiretroviral therapy.

Authors:  Jean B Nachega; Richard E Chaisson; Rene Goliath; Anne Efron; Mohammad A Chaudhary; Malathi Ram; Chelsea Morroni; Hennie Schoeman; Amy R Knowlton; Gary Maartens
Journal:  AIDS       Date:  2010-06-01       Impact factor: 4.177

Review 3.  Impact of metabolic complications on antiretroviral treatment adherence: clinical and public health implications.

Authors:  Jean B Nachega; Maria Paola Trotta; Mark Nelson; Adriana Ammassari
Journal:  Curr HIV/AIDS Rep       Date:  2009-08       Impact factor: 5.071

Review 4.  HIV treatment adherence, drug resistance, virologic failure: evolving concepts.

Authors:  Jean B Nachega; Vincent C Marconi; Gert U van Zyl; Edward M Gardner; Wolfgang Preiser; Steven Y Hong; Edward J Mills; Robert Gross
Journal:  Infect Disord Drug Targets       Date:  2011-04

5.  Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients: a randomized trial.

Authors:  Robert Gross; Camlin Tierney; Adriana Andrade; Christina Lalama; Susan Rosenkranz; Susan H Eshleman; Timothy Flanigan; Jorge Santana; Nadim Salomon; Ronald Reisler; Ilene Wiggins; Evelyn Hogg; Charles Flexner; Donna Mildvan
Journal:  Arch Intern Med       Date:  2009-07-13

6.  Expanding antiretroviral options in resource-limited settings--a cost-effectiveness analysis.

Authors:  Eran Bendavid; Robin Wood; David A Katzenstein; Ahmed M Bayoumi; Douglas K Owens
Journal:  J Acquir Immune Defic Syndr       Date:  2009-09-01       Impact factor: 3.731
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.